See more : Nucleus Software Exports Limited (NUCLEUS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Medley, Inc. (4480.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medley, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Oil and Natural Gas Corporation Limited (ONGC.BO) Income Statement Analysis – Financial Results
- Cimarex Energy Co. (0HYB.L) Income Statement Analysis – Financial Results
- Aplisens S.A. (APN.WA) Income Statement Analysis – Financial Results
- Biomass Secure Power Inc. (BMSPF) Income Statement Analysis – Financial Results
- Arabian Pipes Company (2200.SR) Income Statement Analysis – Financial Results
Medley, Inc. (4480.T)
About Medley, Inc.
Medley, Inc. operates platforms for recruitment and medical businesses in Japan. It operates through three segments: HR Platform Business, Medical Platform Business, and New Services. The company manages JobMedley, a human resource recruitment system for medical and healthcare, and related businesses; CLINICS Telemedicine, a telemedicine system for patients and medical institutions; CLINICS, a cloud medical support system; Pharms pharmacy window support systems; and MEDLEY, a medical information service for patients, as well as Kaigo-no Honne, a website to search nursing care facilities. It also conducts proof-of-concept testing for pharms. Medley, Inc. was incorporated in 2009 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 20.53B | 14.19B | 10.86B | 6.83B | 4.77B | 2.93B | 1.71B |
| Cost of Revenue | 7.18B | 4.46B | 3.88B | 2.16B | 1.55B | 1.08B | 547.29M |
| Gross Profit | 13.36B | 9.72B | 6.99B | 4.67B | 3.21B | 1.85B | 1.17B |
| Gross Profit Ratio | 65.04% | 68.53% | 64.30% | 68.38% | 67.45% | 63.12% | 68.04% |
| Research & Development | 9.00M | 6.00M | 34.86M | 67.47M | 4.56M | 0.00 | 0.00 |
| General & Administrative | 10.04B | 7.53B | 5.68B | 3.96B | 2.88B | 0.00 | 0.00 |
| Selling & Marketing | 669.00M | 710.00M | 396.00M | 239.00M | 190.00M | 0.00 | 0.00 |
| SG&A | 10.72B | 8.24B | 6.08B | 4.20B | 3.07B | 1.95B | 1.13B |
| Other Expenses | 0.00 | 8.43B | 6.25B | 4.28B | 3.06B | -3.10M | -7.57M |
| Operating Expenses | 10.72B | 8.43B | 6.25B | 4.28B | 3.06B | 1.95B | 1.14B |
| Cost & Expenses | 17.90B | 12.89B | 10.13B | 6.43B | 4.61B | 3.03B | 1.68B |
| Interest Income | 0.00 | 11.00M | 235.00K | 36.00K | 15.00K | 15.00K | 146.00K |
| Interest Expense | 11.00M | 11.00M | 18.73M | 10.14M | 7.00M | 2.82M | 1.06M |
| Depreciation & Amortization | 686.00M | 600.00M | 464.92M | 153.79M | 97.99M | 53.87M | 15.44M |
| EBITDA | 4.50B | 2.14B | 1.25B | 586.57M | -211.16M | -94.58M | 45.40M |
| EBITDA Ratio | 21.91% | 14.83% | 11.04% | 8.48% | 5.91% | -1.63% | 2.65% |
| Operating Income | 2.64B | 1.29B | 733.25M | 396.09M | 153.16M | -101.78M | 29.96M |
| Operating Income Ratio | 12.84% | 9.09% | 6.75% | 5.80% | 3.21% | -3.47% | 1.75% |
| Total Other Income/Expenses | 1.17B | 233.00M | 31.86M | 26.54M | -469.30M | -49.49M | 8.00M |
| Income Before Tax | 3.80B | 1.52B | 764.86M | 422.63M | -316.14M | -151.27M | 37.96M |
| Income Before Tax Ratio | 18.52% | 10.74% | 7.04% | 6.19% | -6.63% | -5.16% | 2.22% |
| Income Tax Expense | 1.23B | 502.00M | 206.98M | -33.35M | 65.08M | 2.29M | 2.31M |
| Net Income | 2.57B | 1.02B | 563.00M | 455.99M | -381.23M | -153.56M | 35.65M |
| Net Income Ratio | 12.50% | 7.17% | 5.18% | 6.68% | -8.00% | -5.24% | 2.08% |
| EPS | 79.52 | 31.75 | 17.79 | 15.69 | -14.87 | -5.56 | 1.29 |
| EPS Diluted | 78.54 | 31.14 | 17.15 | 14.48 | -14.87 | -5.56 | 1.29 |
| Weighted Avg Shares Out | 32.27M | 32.03M | 31.66M | 29.06M | 25.64M | 27.62M | 27.62M |
| Weighted Avg Shares Out (Dil) | 32.67M | 32.66M | 32.84M | 31.49M | 25.64M | 27.62M | 27.62M |
Source: https://incomestatements.info
Category: Stock Reports